Dr. Nina Vellani

Dr. Vellani stands as an innovative and dynamic business leader, uniquely blending an entrepreneurial mindset with a robust scientific background. With a proven track record, she has successfully transformed cutting-edge health research technologies into innovative therapies and played a pivotal role in the creation of new companies. As the founder of four Venture Capital Funds, Dr. Vellani has not only demonstrated her expertise as a seasoned investor but has also mentored numerous early-stage companies, guiding them through successful product and portfolio planning while securing essential seed and venture funding.

Her contributions extend beyond financial realms. Dr. Vellani is adept at strategic planning, fostering alliances, and cultivating strategic partnerships. She brings a profound passion to build, mentor, and inspire high-performing collaborations and teams. Her commitment lies in creatively advancing innovative therapies and technologies, steering the creation and acceleration of new companies, all while elevating stakeholder value.

Dr. Vellani possesses a keen ability to expedite business and project goals. This is driven by her in-depth understanding of scientific and operational needs, adept identification of barriers to success, and meticulous monitoring of execution, all while maintaining a strategic overview. Currently serving on the Board of VoxCell Bioinnovation, a leading Canadian 3D Bio-Printing company, she continues to contribute to the forefront of cutting-edge technologies.

Dr. Vellani earned her PhD from the Faculty of Medicine and B.Sc. from the Faculty of Science at the University of British Columbia. Beyond her professional pursuits, she channels her passion into various Charities/Non-Profit organizations.  Dr. Vellani is actively engaged in Fund Raising Events, showcasing her commitment to making a positive impact beyond the boardroom.